NCT05146661

NEURESCUE Device as an Adjunct to Cardiac Arrest

An In-hospital Feasibility Study of the NEURESCUE Device as an Adjunct to Cardiac Arrest

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 10 (actual)
• Sponsor: neurescue · Industry
• Sex: All
• Age: 18 Years – 79 Years
• Healthy volunteers: Not accepted

Summary

The NEURESCUE device is the first intelligent balloon catheter for aortic occlusion, an emergency technique that supercharges blood flow to the heart and brain within one minute from deployment. The catheter-based device is delivered via the femoral artery, temporarily inflating a soft balloon in the descending to redirect blood flow towards the upper body. The objective of the study is to investigate the safety and performance of the NEURESCUE device as an adjunct to Advanced Life Support (ALS) in adults with cardiac arrest.

Conditions

• Cardiac Arrest
• Cardiopulmonary Arrest
• Cardiovascular Diseases

Interventions

Type	Name	Description
DEVICE	NEURESCUE device	The balloon catheter is delivered via the femoral artery, temporarily inflating a soft balloon in the descending to redirect blood flow towards the upper body.

Timeline

• Start date: 2022-08-11
• Primary completion: 2023-11-29
• Completion: 2023-11-30
• First posted: 2021-12-07
• Last updated: 2024-01-05

Locations

2 sites across 1 country: Germany